Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxycycline hyclate, quantity: 115 mg (equivalent: doxycycline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; pregelatinised maize starch; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; sunset yellow fcf; quinoline yellow; macrogol 4000 - doxycycline is indicated in the treatment of infections caused by the following microorganisms: mycoplasma pneumoniae: primary atypical pneumonia; rickettsiae: queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus; chlamydia psittaci: psittacosis; calymmatobacterium (donovania) granulomatis: granuloma inguinale; chlamydia trachomatis: lymphogranuloma venereum, trachoma, inclusion conjunctivitis (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents.); doxycycline is indicated in the treatment of infections caused by the following gram-negative microorganisms: vibrio species: cholera; brucella species: brucellosis (in conjunction with streptomycin); yersinia pestis: plague; francisella tularensis: tularaemia; bartonella bacilliformis: bartonellosis; bacteroides species. doxycycline is active against both pre-erythrocytic and asexual bloodstages of plasmodium falciparum. the tetracyclines are only partially active against the pre-erythrocytic stages of plasmodium vivax, and protection depends on drug suppression of the blood stages. doxycycline has no activity against the relapsing forms (hypnozoites) of plasmodium vivax. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p.vivax. as there are relatively few locations where p.vivax does not co-exist to some extent with p.falciparum, it is recommended that doxycycline should be used routinely with other agents, eg. chloroquine. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum: syphilis; treponema pertenue: yaws; neisseria gonorrhoeae: gonorrhoea. doxycycline may be a useful adjunct to amoebicides in the treatment of acute intestinal amoebiasis. in the treatment of severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is not the drug of choice in the following: any type of staphylococcal infection or infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis, or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxylin should not be used for these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci, (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrow pharma pty ltd - doxycycline -

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - doxycycline hyclate, quantity: 116.3 mg (equivalent: doxycycline, qty 100 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; purified water; hypromellose phthalate; hyprolose; wheat starch; diethyl phthalate; hypromellose; gelatin; povidone; ethanol; shellac; pharmaceutical glaze; carbon black - indications as at 24 march 2004: doxycycline is primarily bacteriostatic and is thought to exert its antimicrobial effect by the inhibition of protein synthesis. doxycycline is active against a wide range of gram positive and gram negative organisms. note: the 50 mg capsule is not a paediatric formulation. doryx is indicated in the treatment of infections caused by the following micro-organisms: mycoplasma pneumoniae: primary atypical pneumonia. rickettsiae: queensland tick typhus, typhus fever and q fever agents of psittacosis. calymmatobacterium (donovania) granulomitis: granuloma inguinale. agents of lymphogranuloma venereum. borreliae: relapsing fever. chlamydia trachomatis. doryx is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doryx alone, or in combination with topical agents. doryx is indicated in the treatment of infections caused by the following gram negative micro-or

Australia - English - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - doxycycline hyclate, quantity: 58.15 mg (equivalent: doxycycline, qty 50 mg) - capsule, modified release - excipient ingredients: microcrystalline cellulose; povidone; magnesium stearate; hypromellose; gelatin; diethyl phthalate; hypromellose phthalate; lactose monohydrate; purified water; wheat starch; hyprolose; ethanol; shellac; pharmaceutical glaze; carbon black - indications as at 24 march 2004: doxycycline is primarily bacteriostatic and is thought to exert its antimicrobial effect by the inhibition of protein synthesis. doxycycline is active against a wide range of gram positive and gram negative organisms. note: the 50 mg capsule is not a paediatric formulation. doryx is indicated in the treatment of infections caused by the following micro-organisms: mycoplasma pneumoniae: primary atypical pneumonia. rickettsiae: queensland tick typhus, typhus fever and q fever agents of psittacosis. calymmatobacterium (donovania) granulomitis: granuloma inguinale. agents of lymphogranuloma venereum. borreliae: relapsing fever. chlamydia trachomatis. doryx is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doryx alone, or in combination with topical agents. doryx is indicated in the treatment of infections caused by the following gram negative micro-or

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - brucella melitensis (unii: oqf85710lz) (brucella melitensis - unii:oqf85710lz) - for temporary relief of symptoms related to brucella infection including chronic fatigue syndrome, fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to brucella infection including chronic fatigue syndrome, fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - brucella melitensis (unii: oqf85710lz) (brucella melitensis - unii:oqf85710lz) - for temporary relief of symptoms related to brucella infection including fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to brucella infection including fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - brucella melitensis (unii: oqf85710lz) (brucella melitensis - unii:oqf85710lz) - for temporary relief of symptoms related to brucella infection including fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration. for temporary relief of symptoms related to brucella infection including fever, sweats, malaise, headache, back pain, neck pain, malodorous sweat, peculiar taste in mouth, and gut inflammation.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - doxycycline monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - doxycycline hyclate (hydrochloride) -

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - colistimethate sodium, quantity: 1 million iu - inhalation - excipient ingredients: - tadim powder for nebuliser solution is indicated for the treatment of colonisation and infections of the lung due to susceptible pseudomonas aeruginosa in patients with cystic fibrosis. consideration should be given to official guidance on the appropriate use of antibacterial agents.